» Articles » PMID: 28325572

Lipid Profile Disturbances in Antipsychotic-naive Patients with First-episode Non-affective Psychosis: A Systematic Review and Meta-analysis

Overview
Journal Schizophr Res
Specialty Psychiatry
Date 2017 Mar 23
PMID 28325572
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Dyslipidaemia is one of the most prevalent metabolic disturbances observed in schizophrenia patients and has been largely attributed to the effects of poor lifestyle habits and adverse effects of antipsychotic treatment. However, less is known whether patients with first-episode non-affective psychosis (FENP) present subthreshold indices of dyslipidaemia. Therefore, we tested the hypothesis whether subclinical lipid profile alterations occur already in antipsychotic-naïve FENP patients.

Methods: In this systematic review and meta-analysis we adhered to the PRISMA guidelines and searched PubMed, CINAHL Complete, Academic Search Complete, ERIC and Health Source: Nursing/Academic Edition from database inception to Dec 12, 2016, for case-control studies measuring the levels of total cholesterol, low- and high-density lipoproteins (LDL and HDL) and triglycerides in patients with FENP and controls. W calculated effect size (ES) estimates as Hedges' g and pooled data using random- or fixed-effects models depending on heterogeneity. Our study was registered in the PROSPERO database (CRD42016051732).

Results: Out of 2466 records identified, 19 studies representing 1803 participants were finally included in our systematic review and meta-analysis. Pooled analysis revealed that FENP patients had significantly lower levels of total cholesterol [ES=-0.16 (95% CI: -0.27, -0.06), p=0.003], LDL [ES=-0.13 (95% CI: -0.24, -0.01), p=0.034] and HDL [ES=-0.27 (95% CI: -0.49, -0.05), p=0.018] as well as significantly higher levels of triglycerides [ES=0.22 (95% CI: 0.11, 0.32), p<0.001] compared to controls. After removing single studies in sensitivity analysis, ES estimate for LDL levels was insignificant.

Conclusions: Antipsychotic-naïve patients with FENP present subclinical dyslipidaemia. Future studies should disentangle whether our findings reflect disease-specific mechanisms.

Citing Articles

Sex differences in the association of overweight with cognitive performance in individuals with first-episode psychosis.

Llaurador-Coll M, Cabezas A, Algora M, Sole M, Vilella E, Sanchez-Gistau V Schizophrenia (Heidelb). 2024; 10(1):95.

PMID: 39438485 PMC: 11496804. DOI: 10.1038/s41537-024-00521-w.


Peripheral Lipid Signatures, Metabolic Dysfunction, and Pathophysiology in Schizophrenia Spectrum Disorders.

Wu S, Panganiban K, Lee J, Li D, Smith E, Maksyutynska K Metabolites. 2024; 14(9).

PMID: 39330482 PMC: 11434505. DOI: 10.3390/metabo14090475.


Ceramides: Shared Lipid Biomarkers of Cardiovascular Disease and Schizophrenia.

Tkachev A, Stekolshchikova E, Morozova A, Anikanov N, Zorkina Y, Alekseyeva P Consort Psychiatr. 2024; 2(3):35-43.

PMID: 39044755 PMC: 11262249. DOI: 10.17816/CP101.


Triglyceride-rich lipoprotein, remnant cholesterol, and apolipoproteins CII, CIII, and E in patients with schizophrenia.

Wang J, Kockx M, Bolek M, Lambert T, Sullivan D, Chow V J Lipid Res. 2024; 65(7):100577.

PMID: 38879166 PMC: 11304881. DOI: 10.1016/j.jlr.2024.100577.


Gender Differences in Prevalence and Associated Factors of Dyslipidemia in Initial-Treatment and Drug-Naïve Schizophrenia Patients.

Deng F, Ma J Neuropsychiatr Dis Treat. 2024; 20:957-966.

PMID: 38737771 PMC: 11088862. DOI: 10.2147/NDT.S457631.